Leslie A. Martin, MD

Caritas St. Elizabeth's Medical Center

Boston, Massachusetts - 02135

CLINICAL TRIALS 1
CONDITIONS2
INTERVENTIONS11
SINCE2005

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer

October 2005 - February 2008

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Immunohistochemistry Staining Method

Laboratory Biomarker Analysis

Study Of Socioeconomic And Demographic Variables

Gene Expression Analysis

Polymorphism Analysis

Polymerase Chain Reaction

Mutation Analysis

Study Of High Risk Factors

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry

Chromogenic In Situ Hybridization

Fluorescent Antibody Technique

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Leslie A. Martin, MD

Caritas St. Elizabeth's Medical Center

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP